These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30785961)

  • 21. A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.
    Paladino D; Yue P; Furuya H; Acoba J; Rosser CJ; Turkson J
    Oncotarget; 2016 Feb; 7(6):7253-67. PubMed ID: 26695438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docoxahexaenoic Acid Induces Apoptosis of Pancreatic Cancer Cells by Suppressing Activation of STAT3 and NF-κB.
    Park M; Lim JW; Kim H
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
    Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
    Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF regulates claudin-2 and -4 expression through Src and STAT3 in MDCK cells.
    García-Hernández V; Flores-Maldonado C; Rincon-Heredia R; Verdejo-Torres O; Bonilla-Delgado J; Meneses-Morales I; Gariglio P; Contreras RG
    J Cell Physiol; 2015 Jan; 230(1):105-15. PubMed ID: 24909426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diesel particle-induced transcriptional expression of p21 involves activation of EGFR, Src, and Stat3.
    Cao D; Bromberg PA; Samet JM
    Am J Respir Cell Mol Biol; 2010 Jan; 42(1):88-95. PubMed ID: 19329556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
    Karni R; Jove R; Levitzki A
    Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
    Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
    Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells.
    Lee SW; Yoo J; Lee SH; Kim D; Kim YM; Kim YT
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):75-9. PubMed ID: 23427943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retraction: Antitumor Activity of Epidermal Growth Factor Receptor-Related Protein Is Mediated by Inactivation of ErbB Receptors and Nuclear Factor-κB in Pancreatic Cancer.
    Cancer Res; 2018 Sep; 78(18):5477. PubMed ID: 30217887
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody-based targeting of CD24 enhances antitumor effect of cetuximab via attenuating phosphorylation of Src/STAT3.
    Chen Z; Wang T; Tu X; Xie W; He H; Wang M; Zhang J
    Biomed Pharmacother; 2017 Jun; 90():427-436. PubMed ID: 28391164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
    Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
    Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.
    Yang L; Lin S; Kang Y; Xiang Y; Xu L; Li J; Dai X; Liang G; Huang X; Zhao C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):31. PubMed ID: 30674340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.
    Sp N; Kang DY; Joung YH; Park JH; Kim WS; Lee HK; Song KD; Park YM; Yang YM
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
    DeArmond D; Brattain MG; Jessup JM; Kreisberg J; Malik S; Zhao S; Freeman JW
    Oncogene; 2003 Oct; 22(49):7781-95. PubMed ID: 14586404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine kinase inhibitor-induced IL-6/STAT3 activation decreases sensitivity of EGFR-mutant non-small cell lung cancer to icotinib.
    Wang J; Wang Y; Zheng C; Hou K; Zhang T; Qu X; Liu Y; Kang J; Hu X; Che X
    Cell Biol Int; 2018 Sep; 42(10):1292-1299. PubMed ID: 29885023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.
    Thakur R; Trivedi R; Rastogi N; Singh M; Mishra DP
    Sci Rep; 2015 May; 5():10194. PubMed ID: 25973915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
    Li R; Yanjiao G; Wubin H; Yue W; Jianhua H; Huachuan Z; Rongjian S; Zhidong L
    Oncotarget; 2017 Mar; 8(12):19354-19364. PubMed ID: 28423613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.
    Wojcik EJ; Sharifpoor S; Miller NA; Wright TG; Watering R; Tremblay EA; Swan K; Mueller CR; Elliott BE
    Oncogene; 2006 May; 25(19):2773-84. PubMed ID: 16407846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.